Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LCORL (Ligand-dependent nuclear receptor corepressor-like protein) is a DNA-binding transcription factor with critical roles in sperm development and regulation of skeletal growth and body size. Genetic variations in LCORL are robustly associated with height and skeletal morphology in humans, as well as rapid growth and body conformation in several animal species. LCORL may act in different isoforms—as a transcription factor and potentially as an accessory protein for polycomb repressive complex 2 (PRC2), which is involved in epigenetic silencing and developmental gene regulation. Despite significant research implicating LCORL in developmental biology and animal breeding, there is currently no evidence for direct pharmacological targeting, nor known small molecule or biologic drugs that interact with LCORL.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ligand-dependent nuclear receptor corepressor-like protein (LCORL).